Clinical Trial: MYLUNG Consortium Part 3: Observational Study
Study Status: Completed
Recruit Status: RECRUITING
Condition: Carcinoma, Non-Small-Cell Lung
Study Type: OBSERVATIONAL
Official Title: Molecularly Informed Lung Cancer Treatment in a Community Cancer Network: A Longitudinal Prospective RWE Study (MYLUNG Consortium Part 3: Observational Study)
Brief Summary:
This longitudinal study looks to quantify the testing timeline, operational barriers, and outcomes of biomarker-guided therapy in a large, community-based, and largely unselected patient population with early stage and advanced stage, treatment-naive non-small cell lung cancer, whether squamous or non-squamous.
Read more